Teva Pharmaceutical (TEVA) – This worldwide pharmaceutical company known for its biogenerics and active pharmaceutical ingredients (APIs) has been in a bull market since 1999.
Its powerful advance makes it an institutional favorite, so whenever it falls to its 50-day moving average, buyers seem to rush to the stock.
The recent pullback to the 50-day moving average resulted in the normal buying, but shoved it from a small flag that tells us that the advance will more than likely continue with a target in the mid-$60s or higher.
S&P rated TEVA a “five-star strong buy” with a price objective of $70.
Related Articles:
- Why You’d Be Crazy to Short China
- Grab a Slice of PZA in These Uncertain Times
- Use Moving Averages to Keep Profits ‘On the Move’
Go Big By Going Small: 5 Small Cap Stocks to Buy Now
Small, innovative companies are watching their earnings explode — and they are the next 10-baggers. Investing pro Louis Navellier reveals his secrets to identifying these small-cap innovators, plus five of his favorite small-cap stocks. Download your FREE profit guide here.
Comments are currently unavailable. Please check back soon.